162 related articles for article (PubMed ID: 11781256)
21. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
Besson A; Robbins SM; Yong VW
Eur J Biochem; 1999 Aug; 263(3):605-11. PubMed ID: 10469123
[TBL] [Abstract][Full Text] [Related]
22. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor.
Sanchez T; Thangada S; Wu MT; Kontos CD; Wu D; Wu H; Hla T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4312-7. PubMed ID: 15764699
[TBL] [Abstract][Full Text] [Related]
23. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine 221 in Crk regulates adhesion-dependent membrane localization of Crk and Rac and activation of Rac signaling.
Abassi YA; Vuori K
EMBO J; 2002 Sep; 21(17):4571-82. PubMed ID: 12198159
[TBL] [Abstract][Full Text] [Related]
25. The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of Fc gamma RIIa to modulate signaling events in myeloid cells.
Ganesan LP; Fang H; Marsh CB; Tridandapani S
J Biol Chem; 2003 Sep; 278(37):35710-7. PubMed ID: 12832410
[TBL] [Abstract][Full Text] [Related]
26. Differential association of phosphatidylinositol 3-kinase, SHIP-1, and PTEN with forming phagosomes.
Kamen LA; Levinsohn J; Swanson JA
Mol Biol Cell; 2007 Jul; 18(7):2463-72. PubMed ID: 17442886
[TBL] [Abstract][Full Text] [Related]
27. PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase.
Mondal S; Ghosh-Roy S; Loison F; Li Y; Jia Y; Harris C; Williams DA; Luo HR
J Immunol; 2011 Dec; 187(11):5783-94. PubMed ID: 22043008
[TBL] [Abstract][Full Text] [Related]
28. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
[TBL] [Abstract][Full Text] [Related]
29. PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.
Wu Y; Dowbenko D; Pisabarro MT; Dillard-Telm L; Koeppen H; Lasky LA
J Biol Chem; 2001 Jun; 276(24):21745-53. PubMed ID: 11279206
[TBL] [Abstract][Full Text] [Related]
30. Analysis of FcgammaRIIA cytoplasmic tail requirements in signaling for serotonin secretion: evidence for an ITAM-dependent, PI3K-dependent pathway.
Daniels AB; Worth RG; Dickstein RJ; Dickstein JS; Kim-Han TH; Kim MK; Schreiber AD
Scand J Immunol; 2010 Apr; 71(4):232-9. PubMed ID: 20384866
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine phosphorylation and Fcgamma receptor-mediated phagocytosis.
Strzelecka A; Kwiatkowska K; Sobota A
FEBS Lett; 1997 Jan; 400(1):11-4. PubMed ID: 9000504
[TBL] [Abstract][Full Text] [Related]
32. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
Unoki M; Nakamura Y
Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
[TBL] [Abstract][Full Text] [Related]
33. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase.
Mahimainathan L; Choudhury GG
J Biol Chem; 2004 Apr; 279(15):15258-68. PubMed ID: 14718524
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN.
Huang J; Kontos CD
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):745-51. PubMed ID: 12006385
[TBL] [Abstract][Full Text] [Related]
36. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
[TBL] [Abstract][Full Text] [Related]
37. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
[TBL] [Abstract][Full Text] [Related]
38. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
39. EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2.
Marcoux N; Vuori K
Oncogene; 2003 Sep; 22(38):6100-6. PubMed ID: 12955089
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
